| Epigenetic silencing of TH1-type chemokines shapes tumour immunity and immunotherapy RLWZ Dongjun Peng, Ilona Kryczek, Nisha Nagarsheth, Lili Zhao, Shuang Wei ... Nature 527, 249–253, 2015 | 1067 | 2015 |
| HOXA9 Reprograms the Enhancer Landscape to Promote Leukemogenesis Y Sun, B Zhou, F Mao, J Xu, H Miao, Z Zou, Y Jang, S Cai, M Witkin, ... Cancer cell 34 (4), 643-658, 2018 | 110 | 2018 |
| MLL1 inhibition reprograms epiblast stem cells to naive pluripotency H Zhang, S Gayen, J Xiong, B Zhou, AK Shanmugam, Y Sun, H Karatas, ... Cell stem cell 18 (4), 481-494, 2016 | 79 | 2016 |
| RBPJ/CBF 1 interacts with L3 MBTL 3/MBT 1 to promote repression of Notch signaling via histone demethylase KDM 1A/LSD 1 T Xu, SS Park, BD Giaimo, D Hall, F Ferrante, DM Ho, K Hori, L Anhezini, ... The EMBO journal 36 (21), 3232-3249, 2017 | 62 | 2017 |
| PRDM16 suppresses MLL1r leukemia via intrinsic histone methyltransferase activity B Zhou, J Wang, SY Lee, J Xiong, N Bhanu, Q Guo, P Ma, Y Sun, RC Rao, ... Molecular cell 62 (2), 222-236, 2016 | 62 | 2016 |
| Differential regulation of the c-Myc/Lin28 axis discriminates subclasses of rearranged MLL leukemia L Chen, Y Sun, J Wang, H Jiang, AG Muntean Oncotarget 7 (18), 25208, 2016 | 32 | 2016 |
| HoxA9 binds and represses the Cebpa +8 kb enhancer L Peng, H Guo, P Ma, Y Sun, L Dennison, PD Aplan, JL Hess, ... Plos one 14 (5), e0217604, 2019 | 7 | 2019 |
| Vitamin D deficiency is associated with increased nontuberculous mycobacteria risk in cystic fibrosis WJ Richter, Y Sun, KJ Psoter, MN Santos, JA Nguyen, A Sidhaye, ... Annals of the American Thoracic Society 18 (5), 913-916, 2021 | 6 | 2021 |
| 3rd World Bronchiectasis Conference AE O’Donnell, TR Aksamit Chronic Obstructive Pulmonary Diseases: Journal of the COPD Foundation 5 (4 …, 2018 | 2 | 2018 |
| Vitamin D deficiency is associated with increased risk of pulmonary nontuberculous mycobacteria in cystic fibrosis W Richter, Y Sun, MN Santos, JA Nguyen, A Sidhaye, K Psoter, KA Cohen, ... A106. NTM: BENCH TO BEDSIDE, A2533-A2533, 2019 | 1 | 2019 |
| Targeting the pyrimidine synthesis pathway for differentiation therapy of acute myelogenous leukemia Y Sun, J Hess Translational Cancer Research, 2017 | 1 | 2017 |
| ACTR-37. ASSOCIATION BETWEEN MGMT PROMOTER METHYLATION SCORE AND SURVIVAL IN PATIENTS WITH GLIOBLASTOMA C Romo, P Shah, Y Sun, X Ye, S Grossman Neuro-Oncology 21 (Suppl 6), vi21, 2019 | | 2019 |
| The role of postradiation temozolomide in patients with newly diagnosed MGMT methylated glioblastoma. Y Sun, CG Romo, P Shah, SA Grossman Journal of Clinical Oncology 37 (15_suppl), e13530-e13530, 2019 | | 2019 |
| HOXA9 Recruitment of Methyltransferase Complexes Alters Enhancer Landscape during Leukemic Transformation YDJH Yuqing Sun, Hongzhi Miao, Zhenhua Zou, Bo Zhou, Kai Ge, Gregory Dressler Blood, 2017 | | 2017 |
| The Role of STAT5 in HOXA9-Associated Leukemia P Ma, Y Sun, J Wang, W Song, T Xu, R Kapur, JL Hess Blood 128 (22), 3919, 2016 | | 2016 |
| Differential Regulation of c-Myc/Lin28 Discriminates Subclasses of Rearranged MLL Leukemia L Chen, Y Sun, J Wang, H Jiang, AG Muntean Blood 126 (23), 163, 2015 | | 2015 |
| Mechanisms of Transcriptional Regulation and Transformation by HOXA9 JL Hess, C Collins, J Bronstein, Y Sun, S Nagaraja Blood 120 (21), SCI-30, 2012 | | 2012 |
Weiping ZouCharles B. de Nancrede Professor of Pathology, Immunology, Biology, and Surgery; University ofVerified email at med.umich.edu
